Cargando…
Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer
PURPOSE: Adjuvant chemotherapy has been associated with loss of bone mineral density (BMD) either as a direct effect or due to glucocorticoids used as supportive care medication. A prospective cohort study was conducted to evaluate changes in BMD from baseline to right after completion of chemothera...
Autores principales: | Christensen, Carina Ørts, Cronin-Fenton, Deirdre, Frøslev, Trine, Hermann, Anne Pernille, Ewertz, Marianne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993804/ https://www.ncbi.nlm.nih.gov/pubmed/27146497 http://dx.doi.org/10.1007/s00520-016-3250-y |
Ejemplares similares
-
Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study
por: Harborg, Sixten, et al.
Publicado: (2020) -
Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer.
por: Bruning, P. F., et al.
Publicado: (1990) -
Bone mineral density change during adjuvant chemotherapy in pediatric osteosarcoma
por: Ahn, Ju Hyun, et al.
Publicado: (2015) -
Obesity and Risk of Recurrence in Patients With Breast Cancer Treated With Aromatase Inhibitors
por: Harborg, Sixten, et al.
Publicado: (2023) -
Does adjuvant chemotherapy change bone mineral density and related serum biomarkers in women with breast cancer?
por: Safaei-Nodehi, Reza, et al.
Publicado: (2017)